Skip to main content

Stocks of generic drug companies fall after more than 40 states file suit alleging price fixing

Forty-four state attorneys general announced the had filed suit against 20 generic drugmakers, including Teva and Mylan.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.